Biogen Reaffirms FY22 Outlook; Q1 Adj. EPS Misses Estimates

While reporting financial results for the first quarter on Tuesday, Biogen Inc. (BIIB) reaffirmed its adjusted earnings and revenue guidance for the full-year 2022.

from RTT - Earnings https://ift.tt/njlQUB8
via IFTTT